Acutus Medical Inc (AFIB) USD0.001

Sell:$0.16Buy:$0.17$0.00 (2.04%)

Prices delayed by at least 15 minutes
Sell:$0.16
Buy:$0.17
Change:$0.00 (2.04%)
Prices delayed by at least 15 minutes
Sell:$0.16
Buy:$0.17
Change:$0.00 (2.04%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
1 March 2024
Takeo MukaiCFO
Sell
Tax related
8,475$0.21$1,779.7572,874
6 February 2024
Tom D. SohnCompany Secretary
Sell
Tax related
7,582$0.17$1,311.69105,009
1 February 2024
Tom D. SohnCompany Secretary
Sell
Tax related
5,709$0.19$1,090.42112,591
1 February 2024
Takeo MukaiCFO
Sell
Tax related
2,869$0.19$547.9881,349
7 January 2024
David Harrison RomanPresident/CEO
Sell
Tax related
24,086$0.19$4,552.25332,134
7 January 2024
Kevin MathewsSenior Vice President
Sell
Tax related
6,342$0.19$1,198.6461,106
1 September 2023
Takeo MukaiCFO
Sell
Tax related
1,729$0.49$843.7584,218
5 August 2023
Tom D. SohnCompany Secretary
Sell
Tax related
433$0.69$298.77118,300
5 August 2023
Kevin MathewsSenior Vice President
Sell
Tax related
134$0.69$92.4667,448
2 August 2023
Takeo MukaiCFO
Sell
Tax related
501$0.71$355.7183,447

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
1 June 2023
David Harrison RomanPresident/CEO
Sell
Tax related
17,290$0.85$14,660.19362,704
1 August 2023
David Harrison RomanPresident/CEO
Sell
Tax related
6,484$0.71$4,603.64356,220
7 January 2024
David Harrison RomanPresident/CEO
Sell
Tax related
24,086$0.19$4,552.25332,134
1 March 2024
Takeo MukaiCFO
Sell
Tax related
8,475$0.21$1,779.7572,874
6 February 2024
Tom D. SohnCompany Secretary
Sell
Tax related
7,582$0.17$1,311.69105,009

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.